Corporate Leadership Lacks Biopharma Expertise & Creates Operational and Cultural Challenges
Pros
-Colleagues in labs and manufacturing sites are knowledgeable, dedicated, and supportive of one another. - Compensation and benefits remain competitive within the contract development and manufacturing industry. - Employees gain meaningful hands-on experience with advanced gene therapy and biologics projects. - Certain facilities feature modern equipment that supports complex production requirements. - Occasional team events and basic perks help build occasional positive moments in the workplace.
Cons
- The executive team consists primarily of finance professionals with limited direct experience in biopharmaceutical operations and quality systems. - Substantial debt accumulation and strategic divestitures occurred without sufficient investment in core manufacturing infrastructure or process improvements. - High employee turnover and repeated layoffs have led to increased workloads, reduced staffing levels, and declining team morale. - Persistent gaps in training, documentation, and maintenance contribute to quality deviations and regulatory compliance difficulties. - Communication between departments is often limited, resulting in unrealistic timelines and frequent project delays. - The company faced significant financial pressures approaching instability prior to the private acquisition. - Professional development opportunities are minimal, recognition is inconsistent, and work-life balance remains challenging for most roles
